Therapeutic Drug Monitoring and Population Pharmacokinetic Analysis of Teicoplanin among Chinese Patients with Gram-Positive Infections in a Tertiary Hospital

Table 4

Basic characteristics of patients included (n = 87).

	± s	Range
Age (year)	58.32 ± 22.52	18–95
Weight (kg)	66.56 ± 11.64	38–115
ALT (U/L)	29.45 ± 31.19	4.4–275.3
AST (U/L)	31.99 ± 34.56	8.0–289.8
ALB (g/L)	33.61 ± 5.62	16.5–43.8
TBil (μmol/L)	14.85 ± 9.78	4.1–81.8
DBil (μmol/L)	6.46 ± 6.04	1.6–40.0
ALP (U/L)	85.00 ± 35.41	24.0–231.1
GGT (U/L)	55.95 ± 71.81	4.7–622.4
Urea (mmol/L)	6.57 ± 3.99	1.23–27.04
Scr (μmol/L)	101.76 ± 106.42	33.1–823.1

ALT: alanine aminotransferase; AST: aspartate aminotransferase; ALB: serum albumin; TBil: total bilirubin; DBil: direct bilirubin; ALP: alkaline phosphatase; GGT: γ-glutamyltransferase; Scr: serum creatinine.